Atomo Diagnostics Secures Long-Term Supply Agreement with Newfoundland Diagnostics

2 min read | January 14, 2025 12:28 PM AEDT | By Team Kalkine Media

Atomo Diagnostics Secures Long-Term Supply Agreement with Newfoundland Diagnostics — Image source: shutterstock

Agreement Details

The exclusive distribution rights for Atomo’s tests in the UK are granted to Newfoundland, while they will hold non-exclusive distribution rights in the EU and Colombia. This follows an upfront order of 50,000 tests, which will be manufactured by Atomo during the current quarter.

Newfoundland has already been distributing Atomo’s HIV Self-Test in the UK and parts of Europe, with success seen in major UK retailers like Boots Pharmacies and Tesco Supermarkets. The expansion into Eastern Europe and Colombia is a key part of the growth strategy under this agreement, especially given the increasing demand for HIV testing in these regions.

Strategic Impact

This long-term agreement solidifies Atomo’s presence in the growing global market for self-testing and supports the company’s international expansion.

Following the announcement, Atomo’s share price surged by more than 55% to 1.9 cents per share as of 14 January 2025.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.